{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-023840","form_type":"8-K","ticker":"CDT","cik":"0001896212","company_name":"CDT Equity Inc.","filed_at":"2025-08-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.541546+00:00","generated_at":"2026-05-17T13:29:53.713019+00:00","sec_items":["4.02"],"event_type":"other_material","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"CDT Equity restates Q1 2025 financials; $0.4M milestone misclassified as R&D","bullets":["On Aug 8, 2025, CDT Equity determined its unaudited Q1 2025 financials should no longer be relied upon.","$0.4 million in milestone payments to Sarborg Limited were misclassified as R&D expense instead of an acquired diagnostic asset.","The restatement requires amendments to the Q1 2025 10-Q, affecting balance sheet, income statement, and cash flows.","The Audit Committee and independent accounting firm CBIZ CPAs agreed on the restatement."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-023840","json":"https://secwatch.observer/filing/0001641172-25-023840.json","markdown":"https://secwatch.observer/filing/0001641172-25-023840.md","text":"https://secwatch.observer/filing/0001641172-25-023840.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1896212/000164117225023840/0001641172-25-023840-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1896212/000164117225023840/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T13:29:53.713019+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"83c5b76096a2fcb79352f2122d51dbf1c0c30d87","claim":"CDT Equity Inc. reported that prior financial statements should not be relied upon.","evidence_excerpt":"On August 8, 2025, CDT Equity Inc. (the “Company”) determined, after discussions with its advisors and CBIZ CPAs P.C., the Company’s independent registered public accounting firm, that the Company’s previously issued unaudited financial statements, and notes related thereto, for the Subject Period (as defined below) should no longer be relied upon due to the restatement described below","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1896212/000164117225023840/0001641172-25-023840-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"non reliance"},{"label":"Auditor","value":"CBIZ CPAs P.C."}],"fact_type":"auditor_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}